Table 3.

Characteristics of patients.

Median age	65 (53–80)
Male/female	7/2
Histological type	6 SCLC/3 NSCLC
Karnofsky index
90–100	5
70–80	2
60–70	2
Median CEA plasma level (min–max)	79 ng/mL (10–388)
Prior treatment
Chemotherapy	100%
Radiotherapy	67%
Surgery	33%
Tyrosine kinase inhibitors	11%
Site of disease
Lung	78%
Mediastinum	78%
Liver	56%
Pancreas	22%
Adrenal	33%
Infradiaphragmatic nodes	33%
Bone	11%
Muscle	11%
Brain	11%
Median delay from initial diagnosis (min–max)	25 months (10–64)